The ongoing flu season continues to cause widespread illness, but experts are already looking ahead to next season. The US Centers for Disease Control and Prevention (CDC) has released new data on the 2024-2025 flu vaccine, which shows promising results. According to the CDC, the vaccine reduced doctor’s visits for flu-like symptoms among children and adolescents by up to 60% and among adults by up to 54%. These findings suggest that the new flu vaccine may be an effective tool in preventing the spread of the flu next season.
However, concerns are growing about the availability of the fall 2025 shots due to a recent cancellation of a key vaccine meeting and the US withdrawal from the World Health Organization. These developments have raised worries that the vaccines will be delayed or in short supply, which could impact public health efforts to combat the flu. As the next season’s flu outbreak approaches, it is essential for experts to work together to ensure that the necessary vaccines are available to protect against emerging strains of the flu virus.
Source: https://www.bostonglobe.com/2025/03/03/metro/fda-cancels-flu-vaccine-meeting